{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:35:01Z","timestamp":1791848101451,"version":"4.3.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05368-w","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:10:59Z","timestamp":1743300659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adjuvant therapies for management of hemorrhagic shock: a narrative review"],"prefix":"10.1186","volume":"29","author":[{"given":"Yann","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Dufour-Gaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Vergnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Giaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lauzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"5368_CR1","unstructured":"World Health Organization (WHO). Injuries and violence [Internet]. 2021 [cited 2024 May 11]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/injuries-and-violence"},{"key":"5368_CR2","first-page":"S3","volume":"60","author":"DS Kauvar","year":"2006","unstructured":"Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma Inj Infect Crit Care. 2006;60:S3-11.","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"5368_CR3","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1097\/TA.0000000000004134","volume":"95","author":"JB Holcomb","year":"2023","unstructured":"Holcomb JB, Dorlac WC, Drew BG, Butler FK, Gurney JM, Montgomery HR, et al. Rethinking limb tourniquet conversion in the prehospital environment. J Trauma Acute Care Surg. 2023;95:e54-60.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.annfar.2013.07.012","volume":"32","author":"J-P Tourtier","year":"2013","unstructured":"Tourtier J-P, Palmier B, Tazarourte K, Raux M, Meaudre E, Ausset S, et al. The concept of damage control: extending the paradigm in the prehospital setting. Ann Fr Anesth R\u00e9animation. 2013;32:520\u20136.","journal-title":"Ann Fr Anesth R\u00e9animation"},{"key":"5368_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jamasurg.2019.3475","volume":"154","author":"T Gauss","year":"2019","unstructured":"Gauss T, Ageron F-X, Devaud M-L, Debaty G, Travers S, Garrigue D, et al. Association of prehospital time to in-hospital trauma mortality in a physician-staffed emergency medicine system. JAMA Surg. 2019;154:1117.","journal-title":"JAMA Surg"},{"key":"5368_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.794561","volume":"8","author":"M Cao","year":"2021","unstructured":"Cao M, Zhao Y, He H, Yue R, Pan L, Hu H, et al. New applications of HBOC-201: a 25-year review of the literature. Front Med. 2021;8: 794561.","journal-title":"Front Med"},{"key":"5368_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000004210","author":"S Durbin","year":"2023","unstructured":"Durbin S, Loss L, Buzzard L, Minoza K, Beiling M, Karsonovich C, et al. Pilot study of frozen platelet extracellular vesicles as a therapeutic agent in hemorrhagic shock in rats. J Trauma Acute Care Surg. 2023. https:\/\/doi.org\/10.1097\/TA.0000000000004210.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17324","author":"CD Knight","year":"2023","unstructured":"Knight CD, Bebarta V, Meledeo MA, Ross E, Wu X, Bynum J, et al. A narrative review of prehospital hemorrhagic shock treatment with non-blood product medications. Transfusion (Paris). 2023. https:\/\/doi.org\/10.1111\/trf.17324.","journal-title":"Transfusion (Paris)"},{"key":"5368_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13054-024-04805-6","volume":"28","author":"NP Juffermans","year":"2024","unstructured":"Juffermans NP, G\u00f6zden T, Brohi K, Davenport R, Acker JP, Reade MC, et al. Transforming research to improve therapies for trauma in the twenty-first century. Crit Care. 2024;28:45.","journal-title":"Crit Care"},{"key":"5368_CR10","doi-asserted-by":"crossref","unstructured":"Cottey L, Smith JE, Watts S. Optimisation of mitochondrial function as a novel target for resuscitation in haemorrhagic shock: a systematic review. BMJ Mil Health. 2023;e002427.","DOI":"10.1136\/military-2023-002427"},{"key":"5368_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.shk.0000143407.90473.cc","volume":"22","author":"WJ Hubbard","year":"2004","unstructured":"Hubbard WJ, Bland KI, Chaudry IH. The role of the mitochondrion in trauma and shock. Shock. 2004;22:395\u2013402.","journal-title":"Shock"},{"key":"5368_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","volume":"360","author":"D Brealey","year":"2002","unstructured":"Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. The Lancet. 2002;360:219\u201323.","journal-title":"The Lancet"},{"key":"5368_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/rccm.201003-0326OC","volume":"182","author":"JE Carr\u00e9","year":"2010","unstructured":"Carr\u00e9 JE, Orban J-C, Re L, Felsmann K, Iffert W, Bauer M, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010;182:745\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"5368_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fmed.2017.00223","volume":"4","author":"JC Duvigneau","year":"2017","unstructured":"Duvigneau JC, Kozlov AV. Pathological impact of the interaction of NO and CO with mitochondria in critical care diseases. Front Med. 2017;4:223.","journal-title":"Front Med"},{"key":"5368_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fmed.2019.00281","volume":"6","author":"X Chu","year":"2019","unstructured":"Chu X, Schwartz R, Diamond MP, Raju RP. A combination treatment strategy for hemorrhagic shock in a rat model modulates autophagy. Front Med. 2019;6:281.","journal-title":"Front Med"},{"key":"5368_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbadis.2019.01.009","volume":"1865","author":"K Subramani","year":"2019","unstructured":"Subramani K, Chu X, Warren M, Lee M, Lu S, Singh N, et al. Deficiency of metabolite sensing receptor HCA2 impairs the salutary effect of niacin in hemorrhagic shock. Biochim Biophys Acta BBA - Mol Basis Dis. 2019;1865:688\u201395.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"5368_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/TA.0000000000000761","volume":"79","author":"KY Jeong","year":"2015","unstructured":"Jeong KY, Suh GJ, Kwon WY, Kim KS, Jung YS, Kye YC. The therapeutic effect and mechanism of niacin on acute lung injury in a rat model of hemorrhagic shock: down-regulation of the reactive oxygen species\u2013dependent nuclear factor \u03baB pathway. J Trauma Acute Care Surg. 2015;79:247\u201355.","journal-title":"J Trauma Acute Care Surg"},{"issue":"e120182","key":"5368_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.120182","volume":"3","author":"CA Sims","year":"2018","unstructured":"Sims CA, Guan Y, Mukherjee S, Singh K, Botolin P, Davila A, et al. Nicotinamide mononucleotide preserves mitochondrial function and increases survival in hemorrhagic shock. JCI Insight. 2018;3(e120182): 120182.","journal-title":"JCI Insight"},{"key":"5368_CR19","doi-asserted-by":"publisher","first-page":"e0291598","DOI":"10.1371\/journal.pone.0291598","volume":"18","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li J, Wang H, Gasior FM, Lee C, Lin S, et al. Nicotinamide restores tissue NAD+ and improves survival in rodent models of cardiac arrest. PLoS ONE. 2023;18:e0291598.","journal-title":"PLoS ONE"},{"key":"5368_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3181\/00379727-144-37656","volume":"144","author":"MA Wurth","year":"1973","unstructured":"Wurth MA, Sayeed MM, Baue AE. Nicotinamide adenine dinucleotide (NAD) content of liver with hemorrhagic shock. Exp Biol Med. 1973;144:654\u20138.","journal-title":"Exp Biol Med"},{"key":"5368_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","volume":"65","author":"EC Graff","year":"2016","unstructured":"Graff EC, Fang H, Wanders D, Judd RL. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism. 2016;65:102\u201313.","journal-title":"Metabolism"},{"key":"5368_CR22","unstructured":"Djadjo S, Bajaj T. Niacin. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jun 27]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541036\/"},{"issue":"10","key":"5368_CR23","doi-asserted-by":"publisher","first-page":"BR282","DOI":"10.12659\/MSM.881975","volume":"17","author":"FL Yang","year":"2011","unstructured":"Yang FL, et al. Rosiglitazone protects against severe hemorragic0020shock-induced organ damage in rats. Med Sci Monit. 2011;17(10):BR282.","journal-title":"Med Sci Monit"},{"key":"5368_CR24","first-page":"1","volume":"3","author":"RS Chima","year":"2010","unstructured":"Chima RS, Hake PW, Piraino G, Mangeshkar P, O\u2019Connor M, Zingarelli B. Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock. Int J Clin Exp Med. 2010;3:1\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"5368_CR25","doi-asserted-by":"publisher","first-page":"G133","DOI":"10.1152\/ajpgi.00262.2009","volume":"298","author":"B Zingarelli","year":"2010","unstructured":"Zingarelli B, Chima R, O\u2019Connor M, Piraino G, Denenberg A, Hake PW. Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-\u03b3 in hemorrhagic shock. Am J Physiol-Gastrointest Liver Physiol. 2010;298:G133\u201341.","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"5368_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/01.shk.0000144132.13900.24","volume":"22","author":"M Abdelrahman","year":"2004","unstructured":"Abdelrahman M, Collin M, Thiemermann C. The peroxisome proliferator-activated receptor-\u03b3 ligand 15-deoxyd 12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. Shock. 2004;22:555\u201361.","journal-title":"Shock"},{"key":"5368_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ejphar.2003.12.032","volume":"486","author":"M Collin","year":"2004","unstructured":"Collin M, Abdelrahman M, Thiemermann C. Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock. Eur J Pharmacol. 2004;486:233\u20135.","journal-title":"Eur J Pharmacol"},{"key":"5368_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1128\/MCB.23.3.1085-1094.2003","volume":"23","author":"L Wilson-Fritch","year":"2003","unstructured":"Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S, et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol. 2003;23:1085\u201394.","journal-title":"Mol Cell Biol"},{"key":"5368_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbrc.2008.11.141","volume":"379","author":"K Fujisawa","year":"2009","unstructured":"Fujisawa K, Nishikawa T, Kukidome D, Imoto K, Yamashiro T, Motoshima H, et al. TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis. Biochem Biophys Res Commun. 2009;379:43\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"5368_CR30","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","volume":"54","author":"I Bogacka","year":"2005","unstructured":"Bogacka I, Xie H, Bray GA, Smith SR. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes. 2005;54:1392\u20139.","journal-title":"Diabetes"},{"key":"5368_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.658362","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhang X, Meng L, Gong M, Li J, Shi W, et al. Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics, and function through the PPAR-\u03b3\/PGC-1\u03b1 signaling pathway. Front Pharmacol. 2021;12: 658362.","journal-title":"Front Pharmacol"},{"key":"5368_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/jcp.21730","volume":"220","author":"J Wu","year":"2009","unstructured":"Wu J, Lin T, Wu KK. Rosiglitazone and PPAR-\u03b3 overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins. J Cell Physiol. 2009;220:58\u201371.","journal-title":"J Cell Physiol"},{"key":"5368_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1191\/0961203305lu2223oa","volume":"14","author":"A Consoli","year":"2005","unstructured":"Consoli A, Devangelio E. Thiazolidinediones and inflammation. Lupus. 2005;14:794\u20137.","journal-title":"Lupus"},{"key":"5368_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107705","volume":"219","author":"S Jamwal","year":"2021","unstructured":"Jamwal S, Blackburn JK, Elsworth JD. PPAR\u03b3\/PGC1\u03b1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders. Pharmacol Ther. 2021;219: 107705.","journal-title":"Pharmacol Ther"},{"key":"5368_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1164\/rccm.201005-0695ED","volume":"182","author":"ED Crouser","year":"2010","unstructured":"Crouser ED. Peroxisome proliferator-activated receptors \u03b3 coactivator\u20131\u03b1: Master regulator of mitochondrial biogenesis and survival during critical illness? Am J Respir Crit Care Med. 2010;182:726\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"5368_CR36","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.2174\/1381612820666140306095106","volume":"20","author":"F Sanchis-Gomar","year":"2014","unstructured":"Sanchis-Gomar F, Garcia-Gimenez J, Gomez-Cabrera M, Pallardo F. Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches. Curr Pharm Des. 2014;20:5619\u201333.","journal-title":"Curr Pharm Des"},{"key":"5368_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/10408444.2017.1351420","volume":"48","author":"MA Davidson","year":"2018","unstructured":"Davidson MA, Mattison DR, Azoulay L, Krewski D. Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Crit Rev Toxicol. 2018;48:52\u2013108.","journal-title":"Crit Rev Toxicol"},{"key":"5368_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cardiores.2004.12.008","volume":"65","author":"M Abdelrahman","year":"2005","unstructured":"Abdelrahman M, Sivarajah A, Thiemermann C. Beneficial effects of PPAR-\u03b3 ligands in ischemia-reperfusion injury, inflammation and shock. Cardiovasc Res. 2005;65:772\u201381.","journal-title":"Cardiovasc Res"},{"key":"5368_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/01.shk.0000160521.91363.88","volume":"23","author":"B Zingarelli","year":"2005","unstructured":"Zingarelli B, Cook JA. Peroxisome proliferator-activated receptor-\u03b3 is a new therapeutic target in sepsis and inflammation. Shock. 2005;23:393\u20139.","journal-title":"Shock"},{"key":"5368_CR40","doi-asserted-by":"publisher","first-page":"7142314","DOI":"10.1155\/2022\/7142314","volume":"2022","author":"R Huang","year":"2022","unstructured":"Huang R, Zou C, Zhang C, Wang X, Zou X, Xiang Z, et al. Protective effects of PPAR\u03b3 on renal ischemia-reperfusion injury by regulating miR-21. Oxid Med Cell Longev. 2022;2022:7142314.","journal-title":"Oxid Med Cell Longev"},{"key":"5368_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.600618","volume":"12","author":"R Huang","year":"2021","unstructured":"Huang R, Zhang C, Wang X, Hu H. PPAR\u03b3 in ischemia-reperfusion injury: overview of the biology and therapy. Front Pharmacol. 2021;12: 600618.","journal-title":"Front Pharmacol"},{"key":"5368_CR42","unstructured":"Quintanilla Rodriguez BS, Correa R. Rosiglitazone. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jun 27]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544230\/"},{"key":"5368_CR43","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41598-024-53945-w","volume":"14","author":"X Wu","year":"2024","unstructured":"Wu X, Cap AP, Bynum JA, Chance TC, Darlington DN, Meledeo MA. Prolyl hydroxylase domain inhibitor is an effective pre-hospital pharmaceutical intervention for trauma and hemorrhagic shock. Sci Rep. 2024;14:3874.","journal-title":"Sci Rep"},{"key":"5368_CR44","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1089\/neu.2018.6364","volume":"36","author":"Y Li","year":"2019","unstructured":"Li Y, Han W, Wu Y, Zhou K, Zheng Z, Wang H, et al. Stabilization of hypoxia inducible factor-1\u03b1 by dimethyloxalylglycine promotes recovery from acute spinal cord injury by inhibiting neural apoptosis and enhancing axon regeneration. J Neurotrauma. 2019;36:3394\u2013409.","journal-title":"J Neurotrauma"},{"key":"5368_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/cc9991","volume":"15","author":"SN Heyman","year":"2011","unstructured":"Heyman SN, Rosen S, Rosenberger C. Hypoxia-inducible factors and the prevention of acute organ injury. Crit Care. 2011;15:209.","journal-title":"Crit Care"},{"key":"5368_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399\u2013408.","journal-title":"Cell"},{"key":"5368_CR47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIF\u03b1 Targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464\u20138.","journal-title":"Science"},{"key":"5368_CR48","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1073\/pnas.1515872112","volume":"112","author":"T Suhara","year":"2015","unstructured":"Suhara T, Hishiki T, Kasahara M, Hayakawa N, Oyaizu T, Nakanishi T, et al. Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle. Proc Natl Acad Sci. 2015;112:11642\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"5368_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.837249","volume":"13","author":"M Miao","year":"2022","unstructured":"Miao M, Wu M, Li Y, Zhang L, Jin Q, Fan J, et al. Clinical potential of hypoxia inducible factors prolyl hydroxylase inhibitors in treating nonanemic diseases. Front Pharmacol. 2022;13: 837249.","journal-title":"Front Pharmacol"},{"issue":"10","key":"5368_CR50","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/ndt\/gfae075","volume":"39","author":"S Stoumpos","year":"2024","unstructured":"Stoumpos S, Crowe K, Sarafidis P, Barratt J, Bolignano D, Del Vecchio L, et al. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association. Nephrol Dial Transplant. 2024;39(10):1710\u201330.","journal-title":"Nephrol Dial Transplant"},{"key":"5368_CR51","doi-asserted-by":"publisher","first-page":"e00248","DOI":"10.1128\/MCB.00248-17","volume":"37","author":"T Oyaizu-Toramaru","year":"2017","unstructured":"Oyaizu-Toramaru T, Suhara T, Hayakawa N, Nakamura T, Kubo A, Minamishima S, et al. Targeting oxygen-sensing prolyl hydroxylase for metformin-associated lactic acidosis treatment. Mol Cell Biol. 2017;37:e00248-e317.","journal-title":"Mol Cell Biol"},{"key":"5368_CR52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/shk.0b013e3180487ebb","volume":"28","author":"LG N\u00f6t","year":"2007","unstructured":"N\u00f6t LG, Marchase RB, F\u00fcl\u00f6p N, Brocks CA, Chatham JC. Glucosamine administration improves survival rate after severe hemorrhagic shock combined with trauma in rats. Shock. 2007;28:345\u201352.","journal-title":"Shock"},{"key":"5368_CR53","doi-asserted-by":"publisher","first-page":"H515","DOI":"10.1152\/ajpheart.01025.2008","volume":"296","author":"L Zou","year":"2009","unstructured":"Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, Marchase RB, et al. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-\u03baB signaling. Am J Physiol-Heart Circ Physiol. 2009;296:H515\u201323.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"5368_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/01.shk.0000209563.07693.db","volume":"25","author":"S Yang","year":"2006","unstructured":"Yang S, Zou L, Bounelis P, Chaudry I, Chatham JC, Marchase RB. Glucosamine administration during resuscitation improves organ function after trauma hemorrhage. Shock. 2006;25:600\u20137.","journal-title":"Shock"},{"key":"5368_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/CCM.0b013e3181cb10b3","volume":"38","author":"LG N\u00f6t","year":"2010","unstructured":"N\u00f6t LG, Brocks CA, V\u00e1mhidy L, Marchase RB, Chatham JC. Increased O-linked \u03b2-N-acetylglucosamine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats. Crit Care Med. 2010;38:562\u201371.","journal-title":"Crit Care Med"},{"key":"5368_CR56","first-page":"119","volume":"15","author":"T Dupas","year":"2023","unstructured":"Dupas T, Aillerie V, Vergnaud A, Erraud A, Persello A, Rozec B, et al. Stimulate acutely the O-GlcNAc levels are beneficial in hemorrhagic shock: Involvement of the Na\/K ATPase. Arch Cardiovasc Dis Suppl. 2023;15:119.","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"5368_CR57","first-page":"195","volume":"15","author":"A Vergnaud","year":"2023","unstructured":"Vergnaud A, Dupas T, Aillerie V, Persello A, Pele T, Blangy-Letheule A, et al. Benefice of the stimulation of O-GlcNAcylation on sodium potassium pump during hemorrhagic shock. Arch Cardiovasc Dis Suppl. 2023;15:195.","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"5368_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113646","volume":"339","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li X, Spasojevic I, Lu L, Shen Y, Qu X, et al. Increasing O-GlcNAcylation is neuroprotective in young and aged brains after ischemic stroke. Exp Neurol. 2021;339: 113646.","journal-title":"Exp Neurol"},{"key":"5368_CR59","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/STROKEAHA.117.016579","volume":"48","author":"M Jiang","year":"2017","unstructured":"Jiang M, Yu S, Yu Z, Sheng H, Li Y, Liu S, et al. XBP1 (X-box\u2013binding protein-1)\u2013dependent O-Glcnacylation is neuroprotective in ischemic stroke in young mice and its impairment in aged mice is rescued by thiamet-G. Stroke. 2017;48:1646\u201354.","journal-title":"Stroke"},{"key":"5368_CR60","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1097\/WNR.0000000000001734","volume":"32","author":"Y He","year":"2021","unstructured":"He Y, Liu H, Liu Y, Li X, Fan M, Shi K, et al. O-GlcNAcase inhibitor has protective effects in intracerebral hemorrhage by suppressing the inflammatory response. NeuroReport. 2021;32:1349\u201356.","journal-title":"NeuroReport"},{"key":"5368_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106289","volume":"151","author":"T Dupas","year":"2022","unstructured":"Dupas T, Betus C, Blangy-Letheule A, Pel\u00e9 T, Persello A, Denis M, et al. An overview of tools to decipher O-GlcNAcylation from historical approaches to new insights. Int J Biochem Cell Biol. 2022;151: 106289.","journal-title":"Int J Biochem Cell Biol"},{"key":"5368_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/SHK.0b013e3181598bad","volume":"29","author":"JC Chatham","year":"2008","unstructured":"Chatham JC, N\u00f6t LG, F\u00fcl\u00f6p N, Marchase RB. Hexosamine biosynthesis and protein O-Glycosylation: the first line of defense against stress, ischemia, and trauma. Shock. 2008;29:431\u201340.","journal-title":"Shock"},{"key":"5368_CR63","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.3390\/cells11213509","volume":"11","author":"KMM Fahie","year":"2022","unstructured":"Fahie KMM, Papanicolaou KN, Zachara NE. Integration of O-GlcNAc into stress response pathways. Cells. 2022;11:3509.","journal-title":"Cells"},{"key":"5368_CR64","doi-asserted-by":"publisher","first-page":"30133","DOI":"10.1074\/jbc.M403773200","volume":"279","author":"NE Zachara","year":"2004","unstructured":"Zachara NE, O\u2019Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. J Biol Chem. 2004;279:30133\u201342.","journal-title":"J Biol Chem"},{"key":"5368_CR65","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.107.730515","volume":"117","author":"SP Jones","year":"2008","unstructured":"Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, et al. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation. 2008;117:1172\u201382.","journal-title":"Circulation"},{"key":"5368_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.yjmcc.2005.11.003","volume":"40","author":"J Liu","year":"2006","unstructured":"Liu J, Pang Y, Chang T, Bounelis P, Chatham J, Marchase R. Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol Cell Cardiol. 2006;40:303\u201312.","journal-title":"J Mol Cell Cardiol"},{"key":"5368_CR67","doi-asserted-by":"publisher","first-page":"9236","DOI":"10.3390\/ijms22179236","volume":"22","author":"M Denis","year":"2021","unstructured":"Denis M, Dupas T, Persello A, Dontaine J, Bultot L, Betus C, et al. An O-GlcNAcylomic approach reveals ACLY as a potential target in sepsis in the young rat. Int J Mol Sci. 2021;22:9236.","journal-title":"Int J Mol Sci"},{"key":"5368_CR68","doi-asserted-by":"publisher","first-page":"18751","DOI":"10.1038\/s41598-019-55381-7","volume":"9","author":"M Ferron","year":"2019","unstructured":"Ferron M, Cadiet J, Persello A, Prat V, Denis M, Erraud A, et al. O-GlcNAc stimulation: a new metabolic approach to treat septic shock. Sci Rep. 2019;9:18751.","journal-title":"Sci Rep"},{"key":"5368_CR69","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.3390\/ijms23126430","volume":"23","author":"T Dupas","year":"2022","unstructured":"Dupas T, Persello A, Blangy-Letheule A, Denis M, Erraud A, Aillerie V, et al. Beneficial effects of O-GlcNAc stimulation in a young rat model of sepsis: beyond modulation of gene expression. Int J Mol Sci. 2022;23:6430.","journal-title":"Int J Mol Sci"},{"key":"5368_CR70","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/01.shk.0000245031.31859.29","volume":"27","author":"L Zou","year":"2007","unstructured":"Zou L, Yang S, Hu S, Chaudry IH, Marchase RB, Chatham JC. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels. Shock. 2007;27:402\u20138.","journal-title":"Shock"},{"key":"5368_CR71","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.mehy.2014.09.018","volume":"83","author":"W Li","year":"2014","unstructured":"Li W, Wang X, He M, Wang C, Qiao Z, Wang Q, et al. Activating Na+\u2013K+ ATPase: a potential cardioprotective therapy during early hemorrhagic shock. Med Hypotheses. 2014;83:685\u20137.","journal-title":"Med Hypotheses"},{"key":"5368_CR72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/cvr\/cvu116","volume":"103","author":"H Liu","year":"2014","unstructured":"Liu H, Wang Z, Yu S, Xu J. Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response\u2020. Cardiovasc Res. 2014;103:131\u20139.","journal-title":"Cardiovasc Res"},{"key":"5368_CR73","doi-asserted-by":"publisher","first-page":"H513","DOI":"10.1152\/ajpheart.01175.2011","volume":"303","author":"RHP Hilgers","year":"2012","unstructured":"Hilgers RHP, Xing D, Gong K, Chen Y-F, Chatham JC, Oparil S. Acute O -GlcNAcylation prevents inflammation-induced vascular dysfunction. Am J Physiol-Heart Circ Physiol. 2012;303:H513\u201322.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"5368_CR74","doi-asserted-by":"publisher","first-page":"H335","DOI":"10.1152\/ajpheart.01259.2007","volume":"295","author":"D Xing","year":"2008","unstructured":"Xing D, Feng W, N\u00f6t LG, Miller AP, Zhang Y, Chen Y-F, et al. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol-Heart Circ Physiol. 2008;295:H335\u201342.","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"5368_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00402-021-04326-9","volume":"143","author":"Z Meng","year":"2022","unstructured":"Meng Z, Liu J, Zhou N. Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis. Arch Orthop Trauma Surg. 2022;143:409\u201321.","journal-title":"Arch Orthop Trauma Surg"},{"key":"5368_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01460-9","author":"A Rabade","year":"2024","unstructured":"Rabade A, Viswanatha GL, Nandakumar K, Kishore A. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis. Inflammopharmacology. 2024. https:\/\/doi.org\/10.1007\/s10787-024-01460-9.","journal-title":"Inflammopharmacology"},{"key":"5368_CR77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10552-018-1003-6","volume":"29","author":"ED Kantor","year":"2018","unstructured":"Kantor ED, Newton CC, Giovannucci EL, McCullough ML, Campbell PT, Jacobs EJ. Glucosamine use and risk of colorectal cancer: results from the cancer prevention study II nutrition cohort. Cancer Causes Control. 2018;29:389\u201397.","journal-title":"Cancer Causes Control"},{"key":"5368_CR78","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2337\/dc19-1836","volume":"43","author":"H Ma","year":"2020","unstructured":"Ma H, Li X, Zhou T, Sun D, Liang Z, Li Y, et al. Glucosamine use, inflammation, and genetic susceptibility, and incidence of type 2 diabetes: a prospective study in UK biobank. Diabetes Care. 2020;43:719\u201325.","journal-title":"Diabetes Care"},{"key":"5368_CR79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg DO, Reda DJ, Harris CL, Klein MA, O\u2019Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795\u2013808.","journal-title":"N Engl J Med"},{"key":"5368_CR80","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. The Lancet. 2001;357:251\u20136.","journal-title":"The Lancet"},{"key":"5368_CR81","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelk\u00e1","year":"2002","unstructured":"Pavelk\u00e1 K, Gatterov\u00e1 J, Olejarov\u00e1 M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled. Double-blind Study Arch Intern Med. 2002;162:2113.","journal-title":"Double-blind Study Arch Intern Med"},{"key":"5368_CR82","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/diabetes.49.6.926","volume":"49","author":"T Monauni","year":"2000","unstructured":"Monauni T, Zenti MG, Cretti A, Daniels MC, Targher G, Caruso B, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes. 2000;49:926\u201335.","journal-title":"Diabetes"},{"key":"5368_CR83","first-page":"2099","volume":"86","author":"M-JJ Pouwels","year":"2001","unstructured":"Pouwels M-JJ, Jacobs JR, Span PN, Lutterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab. 2001;86:2099\u2013103.","journal-title":"J Clin Endocrinol Metab"},{"key":"5368_CR84","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1021\/acs.jmedchem.9b01090","volume":"62","author":"HG Selnick","year":"2019","unstructured":"Selnick HG, Hess JF, Tang C, Liu K, Schachter JB, Ballard JE, et al. Discovery of MK-8719, a potent O-GlcNAcase inhibitor as a potential treatment for tauopathies. J Med Chem. 2019;62:10062\u201397.","journal-title":"J Med Chem"},{"key":"5368_CR85","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.120.266122","volume":"374","author":"X Wang","year":"2020","unstructured":"Wang X, Li W, Marcus J, Pearson M, Song L, Smith K, et al. MK-8719, a novel and selective O -GlcNAcase inhibitor that reduces the formation of pathological tau and ameliorates neurodegeneration in a mouse model of tauopathy. J Pharmacol Exp Ther. 2020;374:252\u201363.","journal-title":"J Pharmacol Exp Ther"},{"key":"5368_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.06.2125","author":"P Sandhu","year":"2016","unstructured":"Sandhu P, Lee J, Ballard J, Walker B, Ellis J, Marcus J, et al. P4\u2013036: pharmacokinetics and pharmacodynamics to support clinical studies of MK-8719: an O-Glcnacase inhibitor for progressive supranuclear palsy. Alzheimers Dement. 2016. https:\/\/doi.org\/10.1016\/j.jalz.2016.06.2125.","journal-title":"Alzheimers Dement"},{"key":"5368_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/alz.040558","volume":"16","author":"S Shcherbinin","year":"2020","unstructured":"Shcherbinin S, Kielbasa W, Dubois S, Lowe SL, Phipps KM, Tseng J, et al. Brain target occupancy of LY3372689, an inhibitor of the O-GlcNAcase (OGA) enzyme: translation from rat to human: neuroimaging\/evaluating treatments. Alzheimers Dement. 2020;16: e040558.","journal-title":"Alzheimers Dement"},{"key":"5368_CR88","unstructured":"Clinical trial\u202f: a study of LY3372689 to assess the safety, tolerability, and efficacy in participants with Alzheimer\u2019s disease [Internet]. 2021. https:\/\/clinicaltrials.gov\/study\/NCT05063539"},{"key":"5368_CR89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.surg.2009.04.007","volume":"146","author":"HB Alam","year":"2009","unstructured":"Alam HB, Shuja F, Butt MU, Duggan M, Li Y, Zacharias N, et al. Surviving blood loss without blood transfusion in a swine poly-trauma model. Surgery. 2009;146:325\u201333.","journal-title":"Surgery"},{"key":"5368_CR90","first-page":"554","volume":"65","author":"ER Gonzales","year":"2008","unstructured":"Gonzales ER, Chen H, Munuve RM, Mehrani T, Nadel A, Koustova E. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock. J Trauma Inj Infect Crit Care. 2008;65:554\u201365.","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"5368_CR91","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jss.2011.06.007","volume":"176","author":"AR Kochanek","year":"2012","unstructured":"Kochanek AR, Fukudome EY, Li Y, Smith EJ, Liu B, Velmahos GC, et al. Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model. J Surg Res. 2012;176:185\u201394.","journal-title":"J Surg Res"},{"key":"5368_CR92","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.surg.2012.03.013","volume":"152","author":"EY Fukudome","year":"2012","unstructured":"Fukudome EY, Li Y, Kochanek AR, Lu J, Smith EJ, Liu B, et al. Pharmacologic resuscitation decreases circulating cytokine-induced neutrophil chemoattractant-1 levels and attenuates hemorrhage-induced acute lung injury. Surgery. 2012;152:254\u201361.","journal-title":"Surgery"},{"key":"5368_CR93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.resuscitation.2010.09.469","volume":"82","author":"N Zacharias","year":"2011","unstructured":"Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, et al. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation. 2011;82:105\u20139.","journal-title":"Resuscitation"},{"key":"5368_CR94","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/TA.0000000000000987","volume":"80","author":"C Wang","year":"2016","unstructured":"Wang C, Wang Y, Qiao Z, Kuai Q, Wang Y, Wang X, et al. Valproic acid\u2013mediated myocardial protection of acute hemorrhagic rat via the BCL-2 pathway. J Trauma Acute Care Surg. 2016;80:812\u20138.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR95","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jss.2009.04.012","volume":"156","author":"MU Butt","year":"2009","unstructured":"Butt MU, Sailhamer EA, Li Y, Liu B, Shuja F, Velmahos GC, et al. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock. J Surg Res. 2009;156:290\u20136.","journal-title":"J Surg Res"},{"key":"5368_CR96","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/TA.0000000000001753","volume":"84","author":"PJ Bruhn","year":"2018","unstructured":"Bruhn PJ, Nikolian VC, Halaweish I, Chang Z, Sillesen M, Liu B, et al. Tubastatin A prevents hemorrhage-induced endothelial barrier dysfunction. J Trauma Acute Care Surg. 2018;84:386\u201392.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR97","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/TA.0000000000000784","volume":"79","author":"Z Chang","year":"2015","unstructured":"Chang Z, Li Y, He W, Liu B, Halaweish I, Bambakidis T, et al. Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock. J Trauma Acute Care Surg. 2015;79:905\u201310.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR98","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/MBC.0000000000000626","volume":"28","author":"T Bambakidis","year":"2017","unstructured":"Bambakidis T, Dekker SE, Halaweish I, Liu B, Nikolian VC, Georgoff PE, et al. Valproic acid modulates platelet and coagulation function ex vivo. Blood Coagul Fibrinolysis Int J Haemost Thromb. 2017;28:479\u201384.","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"5368_CR99","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jss.2014.02.049","volume":"190","author":"SE Dekker","year":"2014","unstructured":"Dekker SE, Sillesen M, Bambakidis T, Andjelkovic AV, Jin G, Liu B, et al. Treatment with a histone deacetylase inhibitor, valproic acid, is associated with increased platelet activation in a large animal model of traumatic brain injury and hemorrhagic shock. J Surg Res. 2014;190:312\u20138.","journal-title":"J Surg Res"},{"key":"5368_CR100","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/TA.0000000000000345","volume":"77","author":"SE Dekker","year":"2014","unstructured":"Dekker SE, Bambakidis T, Sillesen M, Liu B, Johnson CN, Jin G, et al. Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage. J Trauma Acute Care Surg. 2014;77:906\u201312.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR101","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jss.2013.03.087","volume":"184","author":"MW Causey","year":"2013","unstructured":"Causey MW, Miller S, Hoffer Z, Hempel J, Stallings JD, Jin G, et al. Beneficial effects of histone deacetylase inhibition with severe hemorrhage and ischemia-reperfusion injury. J Surg Res. 2013;184:533\u201340.","journal-title":"J Surg Res"},{"key":"5368_CR102","first-page":"629","volume":"64","author":"C Shults","year":"2008","unstructured":"Shults C, Sailhamer EA, Li Y, Liu B, Tabbara M, Butt MU, et al. Surviving blood loss without fluid resuscitation. J Trauma Inj Infect Crit Care. 2008;64:629\u201340.","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"5368_CR103","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jss.2010.04.013","volume":"163","author":"EY Fukudome","year":"2010","unstructured":"Fukudome EY, Kochanek AR, Li Y, Smith EJ, Liu B, Kheirbek T, et al. Pharmacologic resuscitation promotes survival and attenuates hemorrhage-induced activation of extracellular signal-regulated kinase 1\/2. J Surg Res. 2010;163:118\u201326.","journal-title":"J Surg Res"},{"key":"5368_CR104","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/TA.0000000000002281","volume":"87","author":"AM Williams","year":"2019","unstructured":"Williams AM, Bhatti UF, Biesterveld BE, Graham NJ, Chtraklin K, Zhou J, et al. Valproic acid improves survival and decreases resuscitation requirements in a swine model of prolonged damage control resuscitation. J Trauma Acute Care Surg. 2019;87:393\u2013401.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR105","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/TA.0000000000002677","volume":"89","author":"BE Biesterveld","year":"2020","unstructured":"Biesterveld BE, Wakam GK, Kemp MT, Williams AM, Shamshad A, O\u2019Connell RL, et al. Histone deacetylase 6 inhibition improves survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia. J Trauma Acute Care Surg. 2020;89:932\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR106","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/TA.0b013e3182782641","volume":"73","author":"G Jin","year":"2012","unstructured":"Jin G, Duggan M, Imam A, Demoya MA, Sillesen M, Hwabejire J, et al. Pharmacologic resuscitation for hemorrhagic shock combined with traumatic brain injury. J Trauma Acute Care Surg. 2012;73:1461\u201370.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.surg.2013.05.008","volume":"154","author":"AM Imam","year":"2013","unstructured":"Imam AM, Jin G, Duggan M, Sillesen M, Hwabejire JO, Jepsen CH, et al. Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock. Surgery. 2013;154:388\u201396.","journal-title":"Surgery"},{"key":"5368_CR108","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/TA.0000000000001612","volume":"83","author":"VC Nikolian","year":"2017","unstructured":"Nikolian VC, Georgoff PE, Pai MP, Dennahy IS, Chtraklin K, Eidy H, et al. Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma. J Trauma Acute Care Surg. 2017;83:1066\u201373.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR109","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/TA.0000000000000789","volume":"79","author":"I Halaweish","year":"2015","unstructured":"Halaweish I, Bambakidis T, Chang Z, Wei H, Liu B, Li Y, et al. Addition of low-dose valproic acid to saline resuscitation provides neuroprotection and improves long-term outcomes in a large animal model of combined traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2015;79:911\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR110","unstructured":"A randomised controlled trial of pre-surgery sodium valproate, for the prevention of organ injury in cardiac surgery: THE Val-CARD TRIAL [Internet]. 2018 [cited 2018 Nov 6]. https:\/\/clinicaltrials.gov\/study\/NCT03825250"},{"key":"5368_CR111","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jmb.2014.05.025","volume":"427","author":"SE Polo","year":"2015","unstructured":"Polo SE. Reshaping chromatin after DNA damage: the choreography of histone proteins. J Mol Biol. 2015;427:626\u201336.","journal-title":"J Mol Biol"},{"key":"5368_CR112","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/ijms18112247","volume":"18","author":"M Nistor","year":"2017","unstructured":"Nistor M, Behringer W, Schmidt M, Schiffner R. A systematic review of neuroprotective strategies during hypovolemia and hemorrhagic shock. Int J Mol Sci. 2017;18:2247.","journal-title":"Int J Mol Sci"},{"key":"5368_CR113","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32\u201342.","journal-title":"Nat Rev Genet"},{"key":"5368_CR114","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Kim J-S. A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med. 2020;52:204\u201312.","journal-title":"Exp Mol Med"},{"key":"5368_CR115","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.shk.0000209522.28120.c8","volume":"25","author":"E Gonzales","year":"2006","unstructured":"Gonzales E, Chen H, Munuve R, Mehrani T, Britten-Webb J, Nadel A, et al. Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones. Shock. 2006;25:395\u2013401.","journal-title":"Shock"},{"key":"5368_CR116","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/TA.0000000000002721","volume":"89","author":"R Russo","year":"2020","unstructured":"Russo R, Kemp M, Bhatti UF, Pai M, Wakam G, Biesterveld B, et al. Life on the battlefield: valproic acid for combat applications. J Trauma Acute Care Surg. 2020;89:S69-76.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR117","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/TA.0b013e31829d01bf","volume":"75","author":"DW Nelson","year":"2013","unstructured":"Nelson DW, Porta CR, McVay DP, Salgar SK, Martin MJ. Effects of histone deacetylase inhibition on 24-hour survival and end-organ injury in a porcine trauma model: a prospective, randomized trial. J Trauma Acute Care Surg. 2013;75:1031\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR118","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/TA.0000000000003705","volume":"93","author":"WZ Martini","year":"2022","unstructured":"Martini WZ, Xia H, Ryan KL, Bynum J, Cap AP. Valproic acid during hypotensive resuscitation in pigs with trauma and hemorrhagic shock does not improve survival. J Trauma Acute Care Surg. 2022;93:S128\u201335.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2018.11.002","volume":"205","author":"SI Yusoff","year":"2019","unstructured":"Yusoff SI, Roman M, Lai FY, Eagle-Hemming B, Murphy GJ, Kumar T, et al. Systematic review and meta-analysis of experimental studies evaluating the organ protective effects of histone deacetylase inhibitors. Transl Res. 2019;205:1\u201316.","journal-title":"Transl Res"},{"key":"5368_CR120","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). DEPAKINE 500 mg, comprim\u00e9 gastro-r\u00e9sistant - R\u00e9sum\u00e9 des caract\u00e9ristiques du produit [Internet]. Base Donn\u00e9es Publique M\u00e9dicam. 2024 [cited 2024 Jun 26]. https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=60184188"},{"key":"5368_CR121","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jss.2013.09.016","volume":"186","author":"JO Hwabejire","year":"2014","unstructured":"Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB. Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study. J Surg Res. 2014;186:363\u201370.","journal-title":"J Surg Res"},{"key":"5368_CR122","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","volume":"157","author":"V Sharma","year":"2009","unstructured":"Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 2009;157:907\u201321.","journal-title":"Br J Pharmacol"},{"key":"5368_CR123","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-017-0553-1","volume":"57","author":"PE Georgoff","year":"2018","unstructured":"Georgoff PE, Nikolian VC, Bonham T, Pai MP, Tafatia C, Halaweish I, et al. Safety and tolerability of intravenous valproic acid in healthy subjects: a phase I dose-escalation trial. Clin Pharmacokinet. 2018;57:209\u201319.","journal-title":"Clin Pharmacokinet"},{"key":"5368_CR124","unstructured":"A phase 1, single ascending dose, double blind, placebo controlled study to evaluate the safety and tolerability of valproic acid in healthy volunteers (Part 1) or trauma patients(Part 2) [Internet]. 2016 [cited 2016 Nov 1]. https:\/\/clinicaltrials.gov\/study\/NCT02872428"},{"key":"5368_CR125","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/SHK.0b013e318237eb0c","volume":"36","author":"HL Letson","year":"2011","unstructured":"Letson HL, Dobson GP. Unexpected 100% survival following 60% blood loss using small-volume 7.5% NaCl with adenocaine and Mg2+ in the rat model of extreme hemorrhagic shock. Shock. 2011;36:586\u201394.","journal-title":"Shock"},{"key":"5368_CR126","first-page":"708","volume":"71","author":"HL Letson","year":"2011","unstructured":"Letson HL, Dobson GP. Ultra-small intravenous bolus of 75% NaCl\/Mg2+ with adenosine and lidocaine improves early resuscitation outcome in the rat after severe hemorrhagic shock in vivo. J Trauma Inj Infect Crit Care. 2011;71:708\u201319.","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"5368_CR127","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1097\/CCM.0b013e31825334c3","volume":"40","author":"HL Letson","year":"2012","unstructured":"Letson HL, Pecheniuk NM, Mhango LP, Dobson GP. Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaCl adenocaine and Mg2+ in the rat model of severe hemorrhagic shock*. Crit Care Med. 2012;40:2417\u201322.","journal-title":"Crit Care Med"},{"key":"5368_CR128","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/TA.0000000000000587","volume":"78","author":"HL Letson","year":"2015","unstructured":"Letson HL, Dobson GP. Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis. J Trauma Acute Care Surg. 2015;78:773\u201383.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR129","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/TA.0000000000001454","volume":"82","author":"HL Letson","year":"2017","unstructured":"Letson HL, Dobson GP. 3% NaCl adenosine, lidocaine, Mg2+ (ALM) bolus and 4 hours \u201cdrip\u201d infusion reduces noncompressible hemorrhage by 60% in a rat model. J Trauma Acute Care Surg. 2017;82:1063\u201372.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR130","doi-asserted-by":"publisher","first-page":"e0188144","DOI":"10.1371\/journal.pone.0188144","volume":"12","author":"H Letson","year":"2017","unstructured":"Letson H, Dobson G. Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. PLoS ONE. 2017;12:e0188144.","journal-title":"PLoS ONE"},{"key":"5368_CR131","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/SHK.0000000000001886","volume":"57","author":"HL Letson","year":"2022","unstructured":"Letson HL, Biros E, Morris JL, Dobson GP. ALM fluid therapy shifts sympathetic hyperactivity to parasympathetic dominance in the rat model of non-compressible hemorrhagic shock. Shock. 2022;57:264\u201373.","journal-title":"Shock"},{"key":"5368_CR132","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1097\/CCM.0b013e31825fd4ed","volume":"40","author":"A Granfeldt","year":"2012","unstructured":"Granfeldt A, Nielsen TK, S\u00f8lling C, Hyldebrandt JA, Fr\u00f8ki\u00e6r J, Wogensen L, et al. Adenocaine and Mg2+ reduce fluid requirement to maintain hypotensive resuscitation and improve cardiac and renal function in a porcine model of severe hemorrhagic shock*. Crit Care Med. 2012;40:3013\u201325.","journal-title":"Crit Care Med"},{"key":"5368_CR133","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1097\/CCM.0000000000000225","volume":"42","author":"A Granfeldt","year":"2014","unstructured":"Granfeldt A, Letson HL, Hyldebrandt JA, Wang ER, Salcedo PA, Nielsen TK, et al. Small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ has multiple benefits during hypotensive and blood resuscitation in the pig following severe blood loss: rat to pig translation. Crit Care Med. 2014;42:e329\u201344.","journal-title":"Crit Care Med"},{"key":"5368_CR134","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1186\/s13054-014-0682-y","volume":"18","author":"A Granfeldt","year":"2014","unstructured":"Granfeldt A, Letson HL, Dobson GP, Shi W, Vinten-Johansen J, T\u00f8nnesen E. Adenosine, lidocaine and Mg2+improves cardiac and pulmonary function, induces reversible hypotension and exerts anti-inflammatory effects in an endotoxemic porcine model. Crit Care. 2014;18:682.","journal-title":"Crit Care"},{"key":"5368_CR135","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jss.2020.03.048","volume":"253","author":"HL Letson","year":"2020","unstructured":"Letson HL, Granfeldt A, Jensen TH, Mattson TH, Dobson GP. Adenosine, lidocaine, and magnesium support a high flow, hypotensive, vasodilatory state with improved oxygen delivery and cerebral protection in a pig model of noncompressible hemorrhage. J Surg Res. 2020;253:127\u201338.","journal-title":"J Surg Res"},{"key":"5368_CR136","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/TA.0000000000002397","volume":"87","author":"HL Letson","year":"2019","unstructured":"Letson HL, Morris JL, Biros E, Dobson GP. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: a model for studying differential gene expression and extending biological time. J Trauma Acute Care Surg. 2019;87:606\u201313.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR137","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/TA.0000000000002308","volume":"87","author":"RA How","year":"2019","unstructured":"How RA, Glaser JJ, Schaub LJ, Fryer DM, Ozuna KM, Morgan CG, et al. Prehospital adenosine, lidocaine, and magnesium has inferior survival compared with tactical combat casualty care resuscitation in a porcine model of prolonged hemorrhagic shock. J Trauma Acute Care Surg. 2019;87:68\u201375.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR138","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/TA.0000000000003388","volume":"91","author":"J Conner","year":"2021","unstructured":"Conner J, Lammers D, Holtestaul T, Jones I, Kuckelman J, Letson H, et al. Combatting ischemia reperfusion injury from resuscitative endovascular balloon occlusion of the aorta using adenosine, lidocaine and magnesium: a pilot study. J Trauma Acute Care Surg. 2021;91:995\u20131001.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR139","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/TA.0000000000003482","volume":"92","author":"JJ Franko","year":"2022","unstructured":"Franko JJ, Vu MM, Parsons ME, Conner JR, Lammers DT, Ieronimakis N, et al. Adenosine, lidocaine, and magnesium for attenuating ischemia reperfusion injury from resuscitative endovascular balloon occlusion of the aorta in a porcine model. J Trauma Acute Care Surg. 2022;92:631\u20139.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR140","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1007\/s12035-022-03020-0","volume":"59","author":"Y-C Wang","year":"2022","unstructured":"Wang Y-C, Chen Y-S, Hsieh S-T. Neuroprotective effects of a cardioplegic combination (adenosine, lidocaine, and magnesium) in an ischemic stroke model. Mol Neurobiol. 2022;59:7045\u201355.","journal-title":"Mol Neurobiol"},{"key":"5368_CR141","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/TA.0000000000001874","volume":"84","author":"HL Letson","year":"2018","unstructured":"Letson HL, Dobson GP. Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury. J Trauma Acute Care Surg. 2018;84:908\u201316.","journal-title":"J Trauma Acute Care Surg"},{"key":"5368_CR142","doi-asserted-by":"publisher","first-page":"1231759","DOI":"10.3389\/fmed.2023.1231759","volume":"10","author":"GP Dobson","year":"2023","unstructured":"Dobson GP, Morris JL, Letson HL. Adenosine, lidocaine and Mg2+ update: teaching old drugs new tricks. Front Med. 2023;10:1231759.","journal-title":"Front Med"},{"key":"5368_CR143","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jacc.2015.12.071","volume":"67","author":"F Onorati","year":"2016","unstructured":"Onorati F, Dobson GP, San Biagio L, Abbasciano R, Fanti D, Covajes C, et al. Superior myocardial protection using \u201cpolarizing\u201d adenosine, lidocaine, and Mg2+ cardioplegia in humans. J Am Coll Cardiol. 2016;67:1751\u20133.","journal-title":"J Am Coll Cardiol"},{"key":"5368_CR144","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jtcvs.2008.03.025","volume":"136","author":"Z-X Jin","year":"2008","unstructured":"Jin Z-X, Zhang S-L, Wang X-M, Bi S-H, Xin M, Zhou J-J, et al. The myocardial protective effects of a moderate-potassium adenosine\u2013lidocaine cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2008;136:1450\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"5368_CR145","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1093\/ejcts\/ezab466","volume":"61","author":"A Francica","year":"2022","unstructured":"Francica A, Vaccarin A, Dobson GP, Rossetti C, Gardellini J, Faggian G, et al. Short-term outcome of adenosine\u2013lidocaine\u2013magnesium polarizing cardioplegia in humans. Eur J Cardiothorac Surg. 2022;61:1125\u201332.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"5368_CR146","first-page":"22","volume":"2","author":"NG Frangogiannis","year":"2022","unstructured":"Frangogiannis NG. Why animal model studies are lost in translation. J Cardiovasc Aging. 2022;2(2):22.","journal-title":"J Cardiovasc Aging"},{"key":"5368_CR147","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","volume":"4","author":"AA Seyhan","year":"2019","unstructured":"Seyhan AA. Lost in translation: the valley of death across preclinical and clinical divide\u2014identification of problems and overcoming obstacles. Transl Med Commun. 2019;4:18.","journal-title":"Transl Med Commun"},{"key":"5368_CR148","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/SHK.0b013e318285b86d","volume":"39","author":"PE Molina","year":"2013","unstructured":"Molina PE, Sulzer JK, Whitaker AM. Alcohol abuse and the injured host: dysregulation of counterregulatory mechanisms review. Shock. 2013;39:240\u20139.","journal-title":"Shock"},{"key":"5368_CR149","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1111\/j.1537-2995.2012.03618.x","volume":"52","author":"RP Jackman","year":"2012","unstructured":"Jackman RP, Utter GH, Muench MO, Heitman JW, Munz MM, Jackman RW, et al. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion (Paris). 2012;52:2533\u201350.","journal-title":"Transfusion (Paris)"},{"key":"5368_CR150","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jama.2023.4080","volume":"329","author":"P Bouzat","year":"2023","unstructured":"Bouzat P, Charbit J, Abback P-S, Huet-Garrigue D, Delhaye N, Leone M, et al. Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial. JAMA. 2023;329:1367.","journal-title":"JAMA"},{"key":"5368_CR151","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"5368_CR152","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/a-2095-0826","volume":"73","author":"S Kumar","year":"2023","unstructured":"Kumar S, Roy V. Repurposing drugs: an empowering approach to drug discovery and development: drug repurposing for drug development. Drug Res. 2023;73:481\u201390.","journal-title":"Drug Res"},{"key":"5368_CR153","doi-asserted-by":"publisher","first-page":"2161215","DOI":"10.1080\/16078454.2022.2161215","volume":"28","author":"MH Yazer","year":"2023","unstructured":"Yazer MH, Panko G, Holcomb JB, Kaplan A, Leeper C, Seheult JN, et al. Not as \u201cD\u201deadly as once thought \u2013 the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma. Hematology. 2023;28:2161215.","journal-title":"Hematology"},{"key":"5368_CR154","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000004343","author":"N Cazes","year":"2024","unstructured":"Cazes N, Corcostegui S-P, Lovi S, Romary E, Desrobert V, Lidzborski L, et al. Should soldiers take oral tranexamic acid before going into battle? J Trauma Acute Care Surg. 2024. https:\/\/doi.org\/10.1097\/TA.0000000000004343.","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05368-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05368-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05368-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:05:33Z","timestamp":1746191133000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05368-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5368"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05368-w","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliations were incorrectly indicated in the original publication, this article has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}